MedPath

Effect of Low Frequency Ultrasound on Kidney Function

Not Applicable
Completed
Conditions
Chronic Kidney Disease
Registration Number
NCT02026544
Lead Sponsor
Sonogenix
Brief Summary

The purpose of this study is to find out what effect, if any, Low Frequency Therapeutic Ultrasound (LOTUS) has on kidney function in patients with chronic kidney disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Must be >/= 18 years of age
  • Must have documented Stage 3 to Stage 4 (eGFR 15 - 59) chronic kidney disease
  • Females with childbearing potential must not be pregnant at the time of study
  • Subject must provide written informed consent
Exclusion Criteria
  • Unable or unwilling to cooperate with study procedures
  • Currently enrolled in another clinical study for which the follow-up period is not complete

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Glomerular Filtration Rate (GFR)Baseline and 15 minutes after start of Intervention

Absolute change in glomerular filtration rate, GFR, measured by Tc-99m DTPA (diethylenetriamine pentaacetic acid) imaging (Gates Method) in the treated kidney(s) from baseline to during LOTUS

Secondary Outcome Measures
NameTimeMethod
Percent change in GFRBaseline and 15 minutes after start of Intervention

Percent change in GFR in the treated kidney(s) from baseline to during LOTUS.

Blood PressureBaseline and 15 minutes after start of Intervention, and 5 minutes after end of intervention

Blood pressure is measured at baseline, during LOTUS intervention, and immediately after LOTUS intervention

Trial Locations

Locations (1)

Department of Radiology and Biomedical Imaging, UCSF

🇺🇸

San Francisco, California, United States

Department of Radiology and Biomedical Imaging, UCSF
🇺🇸San Francisco, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.